Managing CMC Activities for the Development of Oligonucleotide Therapeutics 2022

Managing Cmc Activities for the Development of Oligonucleotide Therapeutics 2022 is organized by SAE Media Group (SMG) and will be held on Sep 20, 2022 at Copthorne Tara Hotel, London, England, United Kingdom.

Description:
This workshop will examine the CMC development of oligonucleotide therapeutics through interactive discussions. Review the key CMC concepts for oligonucleotide therapeutics and the successes and challenges for the platforms that have already progressed to product approval. Explore the use of oligonucleotides in complex and emerging modalities and assess the next generation of manufacturing platforms. Assess oligonucleotide impurities, their guidelines and how these should be controlled and addressed through interactive discussions. Delve into the regulatory expectations by phase of development and how to plan for the end goal, and understand how this can be applied to future projects.

Benefits of Attending:
• Discuss key developments and challenges in Oligonucleotide CMC
• Explore the use of oligonucleotides in complex and emerging modalities
• Delve into Oligonucleotide impurities, their control and impurity guidelines
• Develop your understanding of the regulatory expectations throughout the different phases of development

Additional details will be posted as soon as information is available.